Literature DB >> 19944293

The role of complementary and alternative therapies in pediatric diabetes.

Sofia Shapiro1, Robert Rapaport.   

Abstract

Complementary and alternative medicine (CAM), also referred to as holistic, or integrative, medicine, are terms that describe a heterogeneous collection of nontraditional therapies, from chemical substances, to biofeedback, to prayer. This review focuses on CAM in pediatric patients with type 1 and type 2 diabetes. CAM prevalence in this population and the specific modalities that have been studied in children are described. Randomized, placebo-controlled, prospective studies in young adults are evaluated for their applicability to pediatric patients. CAM's "complementary" role is emphasized, as there is evidence of significant morbidity when CAM replaces standard-of-care therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944293     DOI: 10.1016/j.ecl.2009.09.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  Complementary and alternative medicine use in children and adolescents with type 1 diabetes.

Authors:  Jean-François Lemay; Aditi Amin; Danièle Pacaud
Journal:  Paediatr Child Health       Date:  2011-10       Impact factor: 2.253

2.  Do patients of integrative anthroposophic pediatric inpatient departments differ? Comparative analysis to all pediatric inpatients in Germany considering demographic and clinical characteristics.

Authors:  Katharina Fetz; Thomas Ostermann; Melanie Schwermer; Sebastian Appelbaum; Jan Vagedes; Tycho Jan Zuzak; Alfred Längler
Journal:  BMC Public Health       Date:  2019-12-03       Impact factor: 3.295

3.  Comparative analysis of resource utilization in integrative anthroposophic and all German pediatric inpatient departments.

Authors:  Katharina Fetz; Alfred Längler; Melanie Schwermer; Clara Carvalho-Hilje; Jan Vagedes; Tycho Jan Zuzak; Thomas Ostermann
Journal:  BMC Health Serv Res       Date:  2020-10-12       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.